Countable Labs, the developer of Countable PCR, a breakthrough single-molecule PCR technology redefining how science measures ...

Countable PCR delivers single-molecule precision for Europe's most demanding quantification challenges — from cell and gene therapy manufacturing to biomarker validation, diagnostics, commercial ...

Countable Labs (formerly Enumerix) enters the genomics market with the launch of Countable PCR, redefining what's possible with PCR for rare event detection. By delivering 10 times more sensitivity ...

Countable Labs has raised $26m to advance the development and commercialisation activities for its single-molecule polymerase chain reaction (PCR) technology. The California-based company's financing ...

DNA and RNA are central to laboratory and clinical research, where quantifying their abundance is key to applications such as gene expression analysis, cell and gene therapy development, and ...

Countable Labs, announced the closing of an oversubscribed $26 million financing round to enable the development of fit-for-purpose solutions leveraging 10-color capabilities to support cell and gene ...

Alex Zevin, PhD, began serving as the director of the Genomics Shared Resource at Fred Hutch in December 2022. Before that, he was a research scientist at ArcherDX where he developed NGS in vitro ...

Countable Labs Brings Innovative, Single-Molecule, Counting-Based PCR to European Markets with CE Mark Clearance Countable PCR delivers single-molecule precision for Europe's most demanding ...

Countable Labs inks agreement with Promega to facilitate biological sample preparation and rare variant detection: Palo Alto, California Monday, June 29, 2026, 16:00 Hrs [IST] Cou ...

PALO ALTO, Calif., May 13, 2025--(BUSINESS WIRE)--Countable Labs (formerly Enumerix) enters the genomics market with the launch of Countable PCR, redefining what’s possible with PCR for rare event ...